A detailed history of Hendley & CO Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Hendley & CO Inc holds 46,210 shares of AZN stock, worth $3.84 Million. This represents 1.29% of its overall portfolio holdings.

Number of Shares
46,210
Previous 46,610 0.86%
Holding current value
$3.84 Million
Previous $3.16 Million 14.12%
% of portfolio
1.29%
Previous 1.13%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 16, 2024

SELL
$66.81 - $80.83 $26,724 - $32,332
-400 Reduced 0.86%
46,210 $3.6 Million
Q4 2023

Jan 26, 2024

SELL
$61.89 - $69.28 $3,094 - $3,464
-50 Reduced 0.11%
46,610 $3.14 Million
Q3 2023

Oct 25, 2023

BUY
$64.85 - $71.7 $2.7 Million - $2.99 Million
41,660 Added 833.2%
46,660 $3.16 Million
Q1 2021

Apr 22, 2021

SELL
$47.16 - $54.44 $188,640 - $217,760
-4,000 Reduced 44.44%
5,000 $249,000
Q3 2020

Oct 21, 2020

BUY
$53.07 - $61.1 $477,630 - $549,900
9,000 New
9,000 $493,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $257B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Hendley & CO Inc Portfolio

Follow Hendley & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hendley & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Hendley & CO Inc with notifications on news.